Schmid John P. — SEC Form 4 filings
SEC reporting owner CIK 1478916. 28 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2024-01-05 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 6 filings — 51,665 shares, $236,054 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 20,645 shares, $1,158,451 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
- Largest priced transaction: sale of 12,596 shares @ $55.71 ($701,707) in ANAPTYSBIO, INC, filed 2026-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | Director | 11 | — | 3 legs · 20,645 sh · $1,158,451 | 38 |
| Design Therapeutics, Inc. (DSGN) | Director | 4 | 2 legs · 26,965 sh · $99,738 | — | 3 |
| BlossomHill Therapeutics, Inc. (BLSM) | Director | 1 | 1 leg · 6,000 sh · $96,000 | — | — |
| Xeris Biopharma Holdings, Inc. (XERS) | Director | 5 | 4 legs · 18,700 sh · $40,315 | — | 1 |
| First Tracks Biotherapeutics, Inc. (TRAX) | Director | 4 | — | — | 18 |
| Poseida Therapeutics, Inc. (PSTX) | Director | 2 | — | — | 11 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | — | 1 | — | — | 2 |
Form 4 filings — Schmid John P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | BlossomHill Therapeutics, Inc. (BLSM) | Purchase (P): 6,000 @ $16 | EDGAR |
| 2026-06-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4/A | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | ANAPTYSBIO, INC (ANAB) | Disposition to issuer (D): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · +14 more | EDGAR |
| 2026-04-22 | 4 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0 · Grant/award (A): 9,200 (derivative) @ $0 · +6 more | EDGAR |
| 2026-04-01 | 4 | ANAPTYSBIO, INC (ANAB) | Sale (S): 12,596 @ $55.71 · Sale (S): 7,527 @ $56.70 · Sale (S): 522 @ $57.40 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ANAPTYSBIO, INC (ANAB) | Other (J): 11,068 @ $51 | EDGAR |
| 2025-08-11 | 4 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Option exercise (M): 30,000 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,030 @ $0 · Option exercise (M): 6,030 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | ANAPTYSBIO, INC (ANAB) | Other (J): 11,068 @ $18.18 | EDGAR |
| 2025-01-15 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 21,692 @ $4.55 · Option exercise (M): 20,645 @ $8.54 · Option exercise (M): 21,692 (derivative) @ $0 · Option exercise (M): 20,645 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Poseida Therapeutics, Inc. (PSTX) | Code (U): 58,950 · Disposition to issuer (D): 32,076 (derivative) @ $0 · Disposition to issuer (D): 16,038 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 25,833 (derivative) @ $0 · +3 more | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 4,515 @ $2.25 | EDGAR |
| 2024-08-12 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 4,285 @ $2.37 | EDGAR |
| 2024-06-18 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 3,900 @ $0 · Option exercise (M): 3,900 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Poseida Therapeutics, Inc. (PSTX) | Grant/award (A): 19,650 @ $0 · Grant/award (A): 27,350 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Design Therapeutics, Inc. (DSGN) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-05-10 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 5,400 @ $1.91 | EDGAR |
| 2024-03-25 | 4 | Design Therapeutics, Inc. (DSGN) | Purchase (P): 9,156 @ $3.62 · Purchase (P): 17,809 @ $3.74 | EDGAR |
| 2024-03-14 | 4 | Xeris Biopharma Holdings, Inc. (XERS) | Purchase (P): 4,500 @ $2.16 | EDGAR |
| 2024-01-05 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 16,510 (derivative) @ $0 · Grant/award (A): 6,030 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1478916 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →